可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]杨学东, 赵连友, 李雪, 等. 精氨酸加压素对大鼠心脏成纤维细胞胶原合成的影响[J]. 心脏杂志, 2000,12: 169-171.
[2]陈永清, 赵连友. p27蛋白表达对精氨酸加压素介导心脏成纤维细胞增殖的影响[J]. 心脏杂志, 2001, 13(2): 122-124.
[3]Diez J, Lopez B, Gonzalez A, et al. Clinical aspects of hypertensive myocardial fibrosis[J]. Curr Opin Cardiol, 2001, 16(6): 328-335.
[4]Vaughan J, Donaldson C, Bittencourt J, et al. Urocortin, a mammalian neuropeptide related to fish urotension I and to corticotropin-releasing factor[J]. Nature, 1995, 378(6554): 287-292.
[5]Weber KT. Fibrosis and hypertensive heart disease[J]. Curr Opin Cardiol, 2000, 15(4): 264-272.
[6]Krzesinski JM, Rorive G, Gauwenberge H. Hypertension and ventricular hypertrophy[J]. Acta Cardiologica, 1996, 2: 143-154.
[7]Kageyama K, Gaudriault GE, Bradbury MJ, et al. Regulation of corticotropin-releasing factor receptor type 2 beta messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids and cytolines[J]. Endocrinoloy, 2000, 141(7): 2285-2293.
[8]Parkes DG, Weisinger RS, May CN. Cardiovascular actions of CRh and urocortin: an update[J]. Peptides, 2001, 22: 821-827.
[9] Baigent SM, Lowry PJ. mRNA expression profiles for corticotropin-releasing factor (CRF), urocotin, CRF receptors and CRF-binding protein in peripheral rat tissues[J]. Jol Endocrinol, 2000, 25: 43-52.
[10] Nishikimi T, Miyata A, Horio T, et al. Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart[J].Am J Physiol, 2000, 279: H3031-H3039.
[11]Spina M, Merlo-Pich E, Chan R, et al. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide[J]. Science, 1996, 273: 1561-1564.
[12]Ikeda K, Tojo K, Oki Y, et al. Urocortin has cell-proliferative effects on cardiac non-myocytes[J]. Life Sciences, 2002, 71: 1929-1938.
[13]Dubey RK, Gillespie DG, Mi Z, et al. Endogenous cyclic AMP-adenosine pathway regulates cardiac fibroblast growth [J]. Hypertension, 2001, 37: 1095-1100.